Quick Answer
IONIS PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $372.26 million for the year ending 2025.
- IONIS PHARMACEUTICALS INC showed an increase of +53.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from IONIS PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 19 years of available data (2007 to 2025), IONIS PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 168.6%.
- Historical annual values: Fiscal year 2025: $372.26 million | Fiscal year 2024: $242.08 million | Fiscal year 2023: $399.27 million | Fiscal year 2022: $276.47 million | Fiscal year 2021: $869.19 million | Fiscal year 2020: $397.66 million | Fiscal year 2019: $683.29 million | Fiscal year 2018: $278.82 million | Fiscal year 2017: $129.63 million | Fiscal year 2016: $84.69 million | Fiscal year 2015: $128.80 million | Fiscal year 2014: $143.00 million | Fiscal year 2013: $159.97 million | Fiscal year 2012: $124.48 million | Fiscal year 2011: $65.48 million | Fiscal year 2010: $70.05 million | Fiscal year 2009: $105.26 million | Fiscal year 2008: $223.99 million | Fiscal year 2007: $138.61 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: